F S&P 500
5,601.00 -1.25 (-0.02%) F Dow Jones
41,154.00 +8.00 (+0.02%) F Nasdaq
19,425.50 -21.75 (-0.11%) E-mini Russell 2000 Index Futur
2,135.90 +3.40 (+0.16%) Petróleo
69.24 +0.27 (+0.39%) Oro
2,591.90 +11.30 (+0.44%)
Sirona Biochem Corp. (SRBCF)
Sirona Biochem Corp.
595 Burrard Street
Vancouver, BC V7X 1L4
Canada
604 641 4466
https://www.sironabiochem.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Howard J. Verrico M.D., Ph.D. | Founder, Chairman of the Board, CEO & Secretary | 134.31k | N/D | 1961 |
| Mr. Christopher D. Hopton C.G.A., CPA | CFO & Director | 109.93k | N/D | 1966 |
| Dr. Géraldine Deliencourt-Godefroy Ph.D. | Chief Scientific Officer & Director | 158.67k | N/D | N/D |
Descripción
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Gestión corporativa
La calificación ISS Governance QuickScore de Sirona Biochem Corp. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
